All In Biotech

Drug Trial Radar · NCT01782352

Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)

Last checked: Nov 19, 2026Latest source record: Aug 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownResults posted on the registryPivotal-lookingRandomized with 25,871 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

25,871

Actual

Start

Jul 2010

Primary completion

Dec 2019

Study completion Sep 2024

Sponsor

Lead sponsor
Brigham and Women's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Eye Institute (NEI)
First posted
Feb 1, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The VITamin D and OmegA-3 Trial (VITAL; NCT 01169259) is a randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL and will examine whether vitamin D or omega-3 fatty acids, compared to placebo, reduce the incidence and/or progression of age-related macular degeneration (AMD).

Conditions

  • Age-related Macular Degeneration

Interventions

  • Omega-3 fatty acids (fish oil)Drug

  • Vitamin D3Dietary supplement

  • Vitamin D3 placeboDietary supplement

  • Fish oil placeboDietary supplement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With an AMD EventTime frame: 5 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Brigham and Women's Hospital

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.